No abstract available.
Meningioma* ; Optic Nerve* ; Orbit*

No abstract available.
Hepatitis B virus* ; Hepatitis B* ; Hepatitis*

No abstract available.
Branchial Region*

No abstract available.
Carcinoma, Squamous Cell* ; Palatine Tonsil* ; Tongue*

No abstract available.
Neurilemmoma*

BACKGROUND: Recent studies revealed that inhalational anesthetics (IA) attenuate NO production. But the hemodynamic changes produced by IA in septic syndrome patient are still sufficient to threaten patient, surgeon and anesthesiologist. So we examined which IA is proper to maintain vascular contractile force and evaluated the effects of NOS inhibitors on contractile force of septic rat aorta under IA. METHODS: Aortic ring preparation was obtained from LPS-treated (1.5 mg/kg, i.p. for 18h) rats. The development of sepsis was confirmed by iNOS activity and iNOS expression using RT-PCR. Contractile responses of aorta to phenylephrine admministation in the presence or absence of halothane, enflurane and isoflurane were evaluated. We also evaluated the effects of NOS inhibitors, one is NG-nitro-L-arginine methyl ester (L-NAME) and the other is aminoguanidine. Statistical significances (p<0.05) were analyzed according to data characteristics by unpaired t-test and paired t-test. RESULTS: The contractile responses to phenylephrine admministration were attenuated in LPS-treated rings. Isoflurane, even at the dose of 2 MAC, didn't affect the contractile response while both halothane and enflurane decreased the contractile response even at the dose of 1 MAC. The potentiation of contractile responses by NOS inhibitors were not affected during administeration of IA. CONCLUSIONS: From these results, it is suggested that isoflurane is the safest inhalational anesthetic and NOS inhibitors, especially L-NAME, may be very useful in the therapy of septic shock patients during general anesthesia.
Anesthesia, General ; Anesthetics* ; Animals ; Aorta ; Enflurane ; Halothane ; Hemodynamics ; Humans ; Isoflurane ; NG-Nitroarginine Methyl Ester ; Nitric Oxide Synthase* ; Nitric Oxide* ; Phenylephrine ; Rats* ; Sepsis ; Shock, Septic

PURPOSE: The purpose of this study was to analyzing the relationship between perceived health status, health locus of control, self-esteem, self-efficacy and HPB in patients with multiple myeloma to identify factors influencing health promoting behavior (HPB). METHODS: One hundred patients were recruited into the study. The data were collected by personal interviews using questionnaires. Descriptive statistics, Pearson's correlation coefficients and stepwise multiple regression analysis were used with SPSS program to were analyze the data. RESULTS: There were significant relationships between self-esteem (r=.787, p<.001), self-efficacy (r=.681, p<.001), internal health locus of control (r=.557, p<.001), powerful others health locus of control (r=.517, p<.001), chance health locus of control (r=-.251, p=.012), perceived health status (r=.532, p<.001) and HPB. Significant factors in explaining HPB were self-esteem, powerful others health locus of control, self-efficacy and perceived health status and together they accounted for 71% of variance. CONCLUSION: The study findings indicate that self-esteem, powerful others health locus of control, self-efficacy, and perceived health status were important factors in explaining HPB in patients with multiple myeloma. As self-esteem was an important variable in HPB, health promotion program designed for this population should focus on self-esteem and these other factors to enhance effective health promotion behavior.
Health Behavior ; Health Promotion ; Humans ; Internal-External Control ; Multiple Myeloma ; Surveys and Questionnaires

No abstract available.
Animals ; Cisplatin* ; Ditiocarb* ; Epithelium* ; Mice* ; Tongue*

No abstract available.
Giant Lymph Node Hyperplasia* ; Neck*

No abstract available.
Angiofibroma* ; Estrogens* ; Progesterone* ; Receptors, Progesterone*